The Long-Acting Dopamine Receptor Agonist Cabergoline in Early Parkinson’s Disease: Final Results of a 5-Year, Double-Blind, Levodopa-Controlled Study.

Autor: Brcicco, Fulvio1, Bcittciglia, Angelo2 angleo.battaglia@pfizer.com, Chouzci, Carlos3, Dupont, Erik4, Gershanik, Oscar5, Masso, Jose Felix Marti6, Montastruc, Jean-Louis7
Zdroj: CNS Drugs. 2004, Vol. 18 Issue 11, p733-746. 14p. 6 Charts, 5 Graphs.
Databáze: Academic Search Ultimate
Externí odkaz: